[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer]

Prostate cancer as a model for tumour immunotherapy

Global sensitivity analysis and model-based reactive scheduling of targeted cancer immunotherapy

Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters

Human myeloid dendritic cells for cancer therapy: does maturation matter?

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms‘ tumor 1 antigen-targeted dendritic cell vaccination

Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients

Advances in cellular therapy for the treatment of thyroid cancer

Anti-HER2 vaccines: new prospects for breast cancer therapy

INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect